Background COPD is an incurable disease and a leading cause of death worldwide. In
mice, fibroblast growth factor (FGF) 10 is essential for lung morphogenesis, and in humans …

Although the positive effects of recombinant fibroblast growth factor-2 (rFGF-2) in chronic
obstructive pulmonary disease (COPD) have been implicated in previous studies …

Fibroblast growth factor 10 (FGF10) plays an important role in mouse lung development,
injury, and repair. It is considered the main morphogen driving lung branching …

Background The defects and imbalance in lung repair and structural maintenance contribute
to the pathogenesis of chronic obstructive pulmonary diseases (COPD), yet the molecular …

Excessive mucus is a hallmark of chronic obstructive pulmonary disease (COPD). There is
an emerging interest in the role of TGF-β signaling in the initiation and progression of COPD …

Lung diseases impact patients across the lifespan, from infants in the first minutes of life
through the aged population. Congenital abnormalities of lung structure can cause lung …

Pulmonary fibrosis (PF) is a chronic, progressive lung disease, characterized by excessive
matrix formation, destruction of the normal lung architecture, dysfunction and finally death …

Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial
pneumonia and the most aggressive form of diffuse parenchymal lung disease …

Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited therapeutic
possibilities. FGF19 (fibroblast growth factor 19), an endocrine FGF, was recently shown to …

The molecular mechanisms underlying the pathogenesis of chronic obstructive pulmonary
disease (COPD) are still unclear, however signaling pathways associated with lung …